Latest news

Debiopharm and ThinkingNodeLife.ai Forge Strategic Partnership to Propel Cancer Drug Development

MedaSystems Secures Additional Funding from Debiopharm Innovation Fund to Accelerate Global Access to Pre-approval Treatment

Debiopharm Extends SunRock Biopharma Partnership for Antibody-Drug Conjugates Targeting HER3 in EGFR Mutated Cancers

Debiopharm and Repare Therapeutics Partner to Explore the Synthetic Lethal Combination of PKMYT1 and WEE1 Inhibition in Cancer

Le 8e Challenge Qualité de vie du patient récompense BOOTIS.CH, plateforme d’organisation de voyages pour les personnes souffrant d’un handicap

Debiopharm invests over 30 million on innovation when its workforce jumped 33% in Valais in one year

Transfer of Marketing Authorization of Anticancer Drug Elplat® to Takata Pharmaceutical

Debiopharm Innovation Fund Launches New Seed Funding Activity to accelerate digital transformation of cancer care and Pharma R&D

Debiopharm Recognizes Pioneering Japanese Cancer Research During The 82nd JCA-Mauvernay Award Ceremony